PharmD Info

A forum for Indian Pharmacy Professionals

Treatment Guidelines - Hospital Institutional Guidelines, Standard Treatment Guidelines, WHO Guidelines, Disease Treatment Guidelines and etc
  • User avatar
#4933
COVID-19 Vaccination

ACIP recommends use of COVID-19 vaccines for everyone ages 12 and older within the scope of the Emergency Use Authorization for the particular vaccine. COVID-19 vaccine and other vaccines may be administered on the same day. See the COVID-19 Vaccine Product Information page for additional information about COVID-19 vaccines authorized for use in the United States.

Consult relevant ACIP statements for detailed recommendations.

For information on contraindications and precautions for the use of a vaccine, consult the General Best Practice Guidelines for Immunization and relevant ACIP statements.

For calculating intervals between doses, 4 weeks = 28 days. Intervals of ≥4 months are determined by calendar months.

Within a number range (e.g., 12–18), a dash (–) should be read as “through.”

Vaccine doses administered ≤4 days before the minimum age or interval are considered valid. Doses of any vaccine administered ≥5 days earlier than the minimum age or minimum interval should not be counted as valid and should be repeated as age-appropriate. The repeat dose should be spaced after the invalid dose by the recommended minimum interval. For further details, see Table 3-
1, Recommended and minimum ages and intervals between vaccine doses, in General Best Practice Guidelines for Immunization.
Information on travel vaccination requirements and recommendations is available at https://remixeducation.in/drugs-and-cosmetics-act/.

For vaccination of persons with immunodeficiencies, see Table 8-1, Vaccination of persons with primary and secondary immunodeficiencies, in General Best Practice Guidelines for Immunization, and Immunization in Special Clinical Circumstances (In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics, 2018:67–111).

For information about vaccination in the setting of a vaccine-preventable disease outbreak, contact your state or local health department.
The National Vaccine Injury Compensation Program (VICP) is a no-fault alternative to the traditional legal system for resolving vaccine injury claims. All routine child and adolescent vaccines are covered by VICP except for pneumococcal polysaccharide vaccine (PPSV23). For more information, see https://remixeducation.in/

You can search on remix education

Pharmacy Council of India, led by Dr. Suresh Bhojr[…]

Dr. B. Suresh resigns from his post - President of[…]

Where do I apply for this job?

Top 20 Indian PCD Pharmaceutical Companies

PCD Pharma Franchise is a growing Business segment[…]

PharmD Info - Highlights